MECHANISM OF AUTOIMMUNE RESPONSE IN HUMAN LUPUS

人类狼疮的自身免疫反应机制

基本信息

  • 批准号:
    6043194
  • 负责人:
  • 金额:
    $ 17.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1993
  • 资助国家:
    美国
  • 起止时间:
    1993-08-01 至 2000-08-22
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (Adapted from Investigator's abstract): The long term objective of this project is to define the fundamental mechanism of the major autoimmune disease, Systemic Lupus Erythematosus (SLE). Analysis of the structure and antigenic specificities of the receptors expressed by the select T helper (TH) cells that induce the production of pathogenic autoantibodies in SLE, may lead to an understanding of the etiologic mechanism of lupus in humans. The goal of the first set of specific aims is to define the antigen receptor mediated signal for the pathogenic autoantibody-inducing Th cells of human lupus. Critical peptide autoepitopes in nucleosomal antigens that trigger lupus Th cells will be identified by eluting naturally processed peptides from MHC molecules and by overlapping peptide synthesis. The disease relevance of the peptide epitopes will be determined in vivo using a SCID-human lupus adoptive transfer system. After fine mapping of MHC and TCR contact residues in the peptide autoepitopes, altered peptide ligands will be designed for blocking pathogenic autoantibody-inducing Th cells from lupus patients. The objective of the second set of specific aims is to define the role of costimulatory signals in the cognate interaction between the select Th and B-cells of lupus that leads to the production of pathogenic autoantibodies. The role of the CD40 ligand molecule (CD40L) in providing the second signal via CD40 on lupus B-cells for production of pathogenic autoantibodies will be studied. The mechanism of hyperexpression of CD40L in the T-cells, and more unexpectedly in the B-cells of lupus patients, will be investigated. Proposed studies on the regulation of CD40L gene expression may reveal an intrinsic defect in lupus which will be important in understanding the basic mechanism of T-cell and B-cell hyperactivity in this disease and will be of diagnostic and prognostic value as well.
描述(改编自研究者摘要):长期目标

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: role of autoimmune T cell receptor alpha chain.
狼疮中核小体自身表位的混杂呈现和识别:自身免疫 T 细胞受体 α 链的作用。
  • DOI:
    10.1084/jem.187.3.367
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Shi,Y;Kaliyaperumal,A;Lu,L;Southwood,S;Sette,A;Michaels,MA;Datta,SK
  • 通讯作者:
    Datta,SK
Lupus: key pathogenic mechanisms and contributing factors.
狼疮:关键致病机制和影响因素。
T cell receptor alpha-chain repertoire of pathogenic autoantibody-inducing T cells in lupus mice.
狼疮小鼠致病性自身抗体诱导 T 细胞的 T 细胞受体 α 链库。
Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells.
Cbl 和丝裂原激活蛋白激酶(细胞外信号相关激酶)途径的调节缺陷导致人狼疮 T 细胞中 CD40 配体持续过度表达。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SYAMAL K DATTA其他文献

SYAMAL K DATTA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SYAMAL K DATTA', 18)}}的其他基金

IMMUNE MECHANISMS OF ANTICD40L TRIAL IN SLE
SLE 中 ANTICD40L 试验的免疫机制
  • 批准号:
    2882256
  • 财政年份:
    1999
  • 资助金额:
    $ 17.86万
  • 项目类别:
IMMUNE MECHANISMS OF ANTICD40L TRIAL IN SLE
SLE 中 ANTICD40L 试验的免疫机制
  • 批准号:
    6137339
  • 财政年份:
    1999
  • 资助金额:
    $ 17.86万
  • 项目类别:
IMMUNE MECHANISMS OF ANTICD40L TRIAL IN SLE
SLE 中 ANTICD40L 试验的免疫机制
  • 批准号:
    6341792
  • 财政年份:
    1999
  • 资助金额:
    $ 17.86万
  • 项目类别:
SEARCH FOR NOVEL B CELL HYPERACTIVITY GENES
寻找新型 B 细胞过度活跃基因
  • 批准号:
    6100391
  • 财政年份:
    1998
  • 资助金额:
    $ 17.86万
  • 项目类别:
SEARCH FOR NOVEL B CELL HYPERACTIVITY GENES
寻找新型 B 细胞过度活跃基因
  • 批准号:
    6235685
  • 财政年份:
    1997
  • 资助金额:
    $ 17.86万
  • 项目类别:
SEARCH FOR NOVEL B CELL HYPERACTIVITY GENES
寻找新型 B 细胞过度活跃基因
  • 批准号:
    6268330
  • 财政年份:
    1997
  • 资助金额:
    $ 17.86万
  • 项目类别:
MECHANISM OF AUTOIMMUNE RESPONSE IN HUMAN LUPUS
人类狼疮的自身免疫反应机制
  • 批准号:
    2457949
  • 财政年份:
    1993
  • 资助金额:
    $ 17.86万
  • 项目类别:
MECHANISM OF AUTOIMMUNE RESPONSE IN HUMAN LUPUS
人类狼疮的自身免疫反应机制
  • 批准号:
    2748628
  • 财政年份:
    1993
  • 资助金额:
    $ 17.86万
  • 项目类别:
MECHANISM OF AUTOIMMUNE RESPONSE IN HUMAN LUPUS
人类狼疮的自身免疫反应机制
  • 批准号:
    6374902
  • 财政年份:
    1993
  • 资助金额:
    $ 17.86万
  • 项目类别:
MECHANISM OF AUTOIMMUNE RESPONSE IN HUMAN LUPUS
人类狼疮的自身免疫反应机制
  • 批准号:
    2079421
  • 财政年份:
    1993
  • 资助金额:
    $ 17.86万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了